12TH INVESTIGATOR INITIATED TRIALS New IIT Content includes Aggregate Spend, M&A, Emerging Markets, Publication Planning and more! SEPTEMBER 27-28, 2010 HYATT REGENCY SAN FRANCISCO Airport - BURLINGAME, CA The ORIGINAL is still the Best! Join us and share Best Practices with organizations including: Abbott Allergan AstraZeneca Celgene Centocor IISRA Johnson & Johnson Merck Millennium Pfizer Vertex Pharmaceuticals 7 th MSL Best Practices Register Today and Gain Access to Presentations from Both Events! CO-LOCATED { PROUDLY PRESENTS Prices Increase After AUGUST 13th To Register Call 866-207-6528 or Visit Us at www.exlpharma.com/events/12th-investigator-initiated-trials SPONSORS & EXHIBITORS: ASSOCIATION PARTNERS: Sunshine Act Pub Planning IP Us Vs. Ex-Us Training Emerging Markets Contracting Mergers & Acquisitions Grants Systems Process Transparency Compliance FMV Safety Reporting Aggregate Spend
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
12th InvestIgator InItIated trIals
New IIT Content includes Aggregate Spend, M&A, Emerging Markets, Publication Planning and more!
September 27-28, 2010Hyatt regency San FranciSco airport - burlingame, ca
The original is still the best!
Join us and share Best Practices with
organizations including:
abbott
allergan
astraZeneca
celgene
centocor
iiSra
Johnson & Johnson
merck
millennium
pfizer
Vertex pharmaceuticals
7th MSL Best PracticesRegister Today and Gain Access to Presentations from Both Events!
Co-LoCated{
PROUDLY PRESENTS
Prices Increase After
August 13th
To Register Call 866-207-6528 or Visit Us at www.exlpharma.com/events/12th-investigator-initiated-trials
SPONSORS & EXHIBITORS:
ASSOcIATION PARTNERS:
Sunshine Act
Pub Planning
IP
Us Vs. Ex-Us Training
Emerging Markets
Contracting
Mergers & Acquisitions
Grants Systems ProcessTransparencyCompliance
FMV
Safety Reporting
Aggregate Spend
SponSorSHip and exHibiting opportunitieSdo you want to spread the word about your or-ganization’s solutions and services to potential clients who will be attending this event? take ad-vantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. exl will work closely with you to customize a package that will suit all of your needs. to learn more about these opportunities, contact lucas carrasco, busi-ness development, by calling 212-400-6231 or by emailing [email protected].
WHO WILL BE IN ATTENDANCE?• InvestigatorInitiated/SponsoredTrials• InvestigatorResearch• MedicalAffairs/FieldMedicalAffairs• MSLManagers/FieldMSLs• ClinicalResearchAssociates• PhaseIV• Legal&RegulatoryAffairs• ClinicalandResearchInvestigators• SiteManagement• Post-MarketStudies• ClinicalAffairs• ClinicalDataAnalysts
“this was an excellent meeting. it covered a broad range of important issues. Speakers are very knowledgeable and very approachable,” Randy Leeder, Clinical Project Manager, Leo PharMa
“excellent, as usual,” Lindsay Tollen, Senior Manager, CePhaLon
“great topics - important issues,” Muriel Siadak, associate Medical Director, SeattLe GenetiCS
“great! exceeded expectations. new data/material; well done presentations, excellent value drive conference!” Patrician Westergren, Product Mgr, iiSr, MeDnet SoLutionS
“yes – no improvements needed,” Coleen Myers, Clinical research Manager, CePhaLon
“great presenter and covered exactly what i was looking for!” Rina Patel, Medical affairs Manager, aLLerGan
“clear, concise info w/good value-added recommendations,” Therica Miller, Manager Clinical trials office, nevada Cancer institute
“yes! great presentations and workshops! good discussions,” Teresa Pena, aD Scientific exchange, uCB
“thoughtful, interactive constantly touching back to mission, goals, value argument,” Laura Williams, Principal Grant and Contract administrator, uMn
rave reviews from exl’s 11th investigator-initiated trials:
HOTEL INFORMATION
to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
Hyatt Regency San FRanciSco airport1333BayshoreHighway,Burlingame,California,USA94010Tel:+16503471234 Fax:+16506962669
reward yourself with a stay at the Four diamond Hyatt regency San Francisco airport hotel. experience our ideal location on San Francisco bay – just 15 minutes from the excitement of downtown San Francisco or the technology corridor of Silicon Valley and only seven minutes from San Francisco international airport, you’ll enjoy easy access to all the sanfrancisco airport attractions surrounding our luxury hotel.
reSerVationS: please make reservations before September 5th
Pre-Co
nfer
enCe
Wo
rk
sho
Pday one, monday, September 27, 20108:00 registration and Continental Breakfast for WorkshoP PartiCiPants
PRE-cONfERENcE WORkSHOP9:00 examining the compliance, execution and data management challenges of tracking aggregate Spend Legal Overview of Sunshine Act
Allocated Time for Questions, Answers and Scenarios for maximum participant involvement
to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
1:15 adopting and implementing processes while maintaining the integrity of trials obtained through mergers and acquisitions Alex Kostek, Global Investigator Initiated Research Group Leader, PFIZer Deborah Cassel, Associate Director, Global Center for Scientific Affairs, Merck Investigator Studies Program (MISP), MerCK • Processoverviewofcompliantlyandefficientlytakingonnew IITsasaresultofmergersandacquisitions • DeterminingwhichIITsshouldbeadoptedandwhichcan contractuallybeletgo • Guidanceonplanningandexecutingintegrationplansin differentscenarios
ONlINE IIT APPROvAl SuBMISSION PROcESS
2:15 case report - on-line automation of iit grants management: System design to global implementation Anton ehrhardt, PhD, Sr. Medical Director, MIllenIUM: THe TAKeDA OnCOlOgY COMPAnY • Advantagesandchallengesofbuildingacompletelycustom system • IntegrationwithexistinginfrastructuretosupportAggregate SpendReporting&TransparencyInitiatives • Whyyoushouldconsiderdoingthistoo
3:15 netWorking and refreshment Break
3:45 understanding the role of publication planning Valérie Philippon, PhD, Director, Publications, VerTeX PHArMACeUTICAlS •PublicationPlanningOverview •IncorporatingthePublicationClauseintheIITAgreement •MaximizingtheValueofPublications •DifferencesbetweenIITandClinicalPublicationReview
Attendees will have additional topic roundtables to choose from focusing on MSL-related topics
6:00 Close of day one
main ConferenCe oPens
to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
8:00 Continental Breakfast for ConferenCe PartiCiPants
8:50 chairperson’s day one recap Karen Bartels, RN, OCN, MBA, PMP, Clinical Project Manager, ASTrAZeneCA & eXeCUTIVe DIreCTOr, IISrA
kEy PERfORMANcE INdIcATORS
9:00 How to terminate an iit and maintain relationships with investigators Ashwaq Hermes, PharmD Sr. Clinical Science ManagerGlobal Pharmaceutical Research & Development, ABBOTT
9:45 walking the compliance tightrope – do you Have a Funambulist on your Staff? Joseph Bray, Product Lead, UBC: envision
Compliance today is a hot button discussion on everyone’sagenda. What is an acceptable risk for one company is toxic toanother.Whataretherules?Whogetstointerpretthem?IsyourSOP compliant in today’s world? How do we bring globalIIT programs together under one set of working practices?What constitutes influence? Small or large: biotech, Pharma,or device company, we all have a lot of the same questions. Inthis session we will attempt to look at both sides of the manydecisions each company must make when developing acompliantIITprogram.
11:00 implementing competitive grants programs in place of iir Submissions Alison Curtin, Associate Director, Global IIR Primary Care, PFIZer
A product team or disease area may choose to implement acompetitivegrantprograminadditiontoorinplaceofacceptingindividual IIR submissions. This type of program typically hasa defined set of research criteria, which is broadly publicizedto an appropriate investigator group through one of severalpossible routes (ie professional journal or website). Submittedapplications are then are reviewed and approved by an externaladvisorycommittee,inlieuofaformalinternalreview. Thistype
ofprogramhasitsbenefits,butalsoitschallenges. Iwilldiscusstheseandhighlightsomekeypointsthat,basedonmyexperience,should be taken into account when setting up a competitiveprogram. Theseinclude:
11:45 How the Sunshine act has impacted iit programs and investigator interactions Dennis Decktor, PhD, MBA, Senior Director, Medical Affairs, CenTOCOr OrTHO-BIOTeCH
12:30 lunCh
INTERNATIONAl IITS
1:30 iit contracting Strategies Annette S. Meints, RN, MS, PMP, Clinical Research Manager II, GPRD, ABBOTT
day two, tueSday, September 28, 2010main ConferenCe
Group Discount proGram
Save 25% per person when Registering Four* Foreverythreesimultaneousregistrationsfromyourcompany,youwillreceiveafourthcomplimentaryregistrationtotheprogram(mustregister4atonetime)thisisasavingsof25%perperson.
Save 15% per person when Registering Three* Canonlysendthree?Youcanstillsave15%offofeveryregistration.
MakecheckspayabletoExL Events, Inc. and write code P1605 on your check. YoumayalsouseVisa,MasterCard,DiscoverorAmericanExpress.Paymentsmustbereceivedinfullpriortothecommencementoftheconference.Cancellations:Ifyouneedtocancelyourregistrationforanupcom-ingExLconference,pleasenotethefollowingpoliciesderivedfromtheStartDateoftheevent:• Four weeks or more:Afullrefund(minusa$95processingfee),oravouchertoanotherExLeventvalidfortwoyearsfromthevoucherissuedate.• Four weeks or Less:AvouchertoanotherExLeventvalidfortwoyearsfromthevoucherissuedate.•Toreceivearefundorvoucher,pleasefaxyourrequestto888-221-6750.• There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague oc-curring within five business days of the conference.Please Note:Speakersandagendaaresubjecttochangewithoutnotice.Intheeventofaspeakercancellation,everyefforttofindasuitablereplacementwillbemade.